STAT Plus: The new Janet: The FDA turns to a quiet problem-solver who brings expertise — and a little controversy
WASHINGTON — Janet Woodcock, one of the FDA’s most powerful regulators, has an almost mythic reputation and an outsized personality to match. For years, rumors have swirled: Who could possibly succeed her?
Now, it seems, there’s an answer to that question: The FDA official who has been tapped to step into Woodcock’s role for at least a temporary stint is a relative newcomer — and until now, a relatively quiet, low-profile presence at an agency that has been thrust into the spotlight amid the coronavirus pandemic.
